About
TCGX Acquisition Corp. II
TCGX Acquisition Corp. II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.
The company profile, business description, and key company details are provided by S&P Global Market Intelligence. The list of executives is sourced from SEC.gov. Recent SEC filings are sourced directly from SEC.gov.
TCGX Acquisition Corp. II Overview
Ticker, listing venue and issuer profile
Offer & Key Dates
Pricing terms and IPO milestones
Change from offer price to today
Live Market Snapshot
Real-time price; headline % change is vs first trade (listing price)
USD · NASDAQ:NASDAQ:TCXB
Valuation & Multiples
Key valuation ratios and metrics
Financial Health
Balance sheet strength and liquidity
Financial Highlights
Historical financial performance
Historical Data
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-10-30 | $10.15 | $10.20 | $10.05 | $10.14 | $10.14 | -0.01 | 8,000 |
| 2026-10-29 | $10.20 | $10.21 | $10.20 | $10.21 | $10.21 | +0.01 | 600 |
| 2026-10-28 | $10.29 | $10.29 | $10.27 | $10.27 | $10.27 | -0.02 | 11,900 |
| 2026-10-27 | $10.28 | $10.28 | $10.28 | $10.28 | $10.28 | 0.00 | 1,600 |
| 2026-10-26 | $10.37 | $10.48 | $10.25 | $10.27 | $10.27 | -0.10 | 3,200 |
| 2026-10-23 | $10.48 | $10.49 | $10.48 | $10.49 | $10.49 | +0.01 | 1,700 |
| 2026-10-22 | $10.57 | $10.57 | $10.47 | $10.50 | $10.50 | -0.07 | 37,200 |
| 2026-10-21 | $10.50 | $11.71 | $10.50 | $10.50 | $10.50 | 0.00 | 23,000 |
| 2026-10-20 | $10.39 | $10.76 | $10.37 | $10.56 | $10.56 | +0.17 | 27,300 |
| 2026-10-19 | $10.60 | $10.71 | $10.34 | $10.40 | $10.40 | -0.20 | 124,500 |
| 2026-10-16 | $11.20 | $11.74 | $10.82 | $10.86 | $10.86 | -0.34 | 698,100 |
SEC Filings
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| SCHEDULE 13G | Oct 26, 2026 | Filing |
| SCHEDULE 13G | Oct 26, 2026 | Filing |
| 8-K12B | Oct 23, 2026 | Filing |
| SCHEDULE 13G | Oct 23, 2026 | Filing |
| SCHEDULE 13G | Oct 23, 2026 | Filing |
| 8-K | Oct 19, 2026 | Current Report |
| 424B4 | Oct 16, 2026 | Prospectus |
| EFFECT | Oct 15, 2026 | Notice of Effectiveness |
| CERT | Oct 15, 2026 | Certification by an exchange approving securities for listing |
| 8-A12B | Oct 15, 2026 | Registration of securities |
Company Info
Contact and headquarters details
Leadership
Key executives and officers
Chen Yu, M.D., M.B.A.
Chief Executive Officer and Director
Craig Skaling
Chief Financial Officer and Director
Joshua Cohen
Director Nominee
Mark McKenna
Director Nominee
Michael Henderson
Director Nominee
